The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies
Year: 2009
Type: preprint
Abstract: We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It will serve as a baseline for the scenario in future.(Article freely downloadable from the journal website.)
Source: SSRN Electronic Journal
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W2264338620
